Journal profile · Medicine-General Medicine

Open Medicine

ISSN 2391-5463 · Walter de Gruyter · POLAND

Open Medicine: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.84; fully open access; APC charged, amount not published; median 160 days to acceptance (116 articles, last 24 months); 250 articles in 2025; indexed in SCIE and Scopus.

Impact factor1.84Latest value listed by LetPub
CAS zoneZone 4 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 4 · Medicine
Review time160 daysMedian, submission to acceptance · 116 articles, last 24 months · PubMed
APCCharged, amount not publishedFully open access
Acceptance—No reports yet
Articles per year2502025 · OpenAlex count

Scope

Aims, scope and focus

Open Medicine is published by Walter de Gruyter and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Cancer-related molecular mechanisms research, MicroRNA in disease regulation and Circular RNAs in diseases, together about 33.5% of its articles. (generated from OpenAlex topic counts and CAS ranking data)

The journal aims to promote knowledge directly relevant to all fields of biomedical science. Subject areas suitable for publication include, but are not limited to, the following:

From the journal's Aims & Scope

Research area (LetPub): Medicine-General Medicine

Editor-in-chief Vittorio CalabresePublisher website

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Cancer-related molecular mechanisms researchBiochemistry, Genetics and Molecular Biology12.7%
  2. MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology11.1%
  3. Circular RNAs in diseasesBiochemistry, Genetics and Molecular Biology9.8%
  4. RNA modifications and cancerBiochemistry, Genetics and Molecular Biology6.7%
  5. Ferroptosis and cancer prognosisMedicine6%
  6. Liver Disease Diagnosis and TreatmentMedicine3.9%
  7. COVID-19 Clinical Research StudiesMedicine3.3%
  8. Venous Thromboembolism Diagnosis and ManagementMedicine3.1%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorMedicine, General & InternalZone 4

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorMedicine, General & InternalZone 4

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorMedicine, General & InternalZone 4

Top journal: noReview journal: no

Database indexing

SCIEScopusDOAJLetPub

International journal early-warning lists: not listed in any editionLetPub

Indexing the journal's website claims

CASPublisher website

Other: EBSCO, ProQuest, AGRICOLA, OCLC

As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor
1.84LetPub ·
Impact factor (publisher)
1.8Publisher website ·
5-year impact factor (publisher)
1.9Publisher website ·
CiteScore 2026-06
3.1LetPub ·
CiteScore (publisher)
3.1Publisher website ·
SJR 2026-06
0.53LetPub ·
SNIP 2026-06
0.55LetPub ·
h-index
24LetPub ·
h-index
49OpenAlex ·
i10-index
607OpenAlex ·
2-year mean citedness
1.77OpenAlex ·
Self-citation rate
0%LetPub ·
Share of gold OA articles
100%LetPub ·

Volume

Articles per year
240LetPub ·

Articles by year OpenAlex count · 2,867 in total · the current year is incomplete

YearArticlesOpen accessCitations
202617517528
2025250250385
2024218218722
20232552551,360
20221991991,840
20212002002,166

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with PubMed · to

160 daysMedian, submission to acceptance · P25–P75 124 days – 225 days

Acceptance to online
median 51 days (116 articles)
Submission to online
median 225 days
Sample
116 articles with submission and acceptance dates (454 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Average review time (community reports)
about 20 weeksLetPub ·
Submission to publication (journal-reported)
about 15 weeksDOAJ ·
Peer review
Single anonymous peer reviewDOAJ

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessDOAJ

Every article is open access; authors usually pay an article processing charge (APC).

SourceAPCFee waiverLicenseObserved
DOAJEUR 2,100YesCC BY
OpenAlexEUR 2,100——
LetPubEUR 2,000Yes—
Publisher websiteEUR 2,000 / EUR 2,100——

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

Policy excerpts from the journal's websitePublication ethics
Publication ethics Publication Ethics and Editorial Policies

Detailed information on Editorial Policy, Publication Ethics, Instructions for Authors etc. can be found in the Supplementary Materials section.

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
Walter de Gruyter
Country or region
POLAND
Language
English
ISSN
2391-5463
Official links

FAQ

Frequently asked questions about Open Medicine

What CAS zone is Open Medicine in?

In the 2025 upgraded edition of the CAS Journal Ranking, Open Medicine is in Zone 4 of Medicine, and in Zone 4 of the minor category Medicine, General & Internal. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of Open Medicine?

The latest impact factor listed by LetPub is 1.84; CiteScore 3.1, h-index 49.

How long does peer review take at Open Medicine?

Based on the dates recorded on 116 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 160 days (interquartile range 124–225 days); authors report an average review time of about 20 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Which databases index Open Medicine?

According to LetPub and DOAJ records, Open Medicine is indexed in SCIE, Scopus and DOAJ. The journal's website also lists CAS; that list has not been checked against each database.

Is Open Medicine open access, and what is the APC?

Open Medicine is a fully open-access journal. APC charged, amount not published.

Sources and updates

The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .